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ABSTRACT
Influences of Anti-Bd Bacteria on Amphibians and their Microbiomes
Emme L. Schmidt
Director: Jake Kerby, Ph.D.

The fungal pathogen Batrochochytrium dendrobatidis (Bd) has been threatening
amphibian populations across the globe. Recent work has discovered that bacteria
isolated from certain populations of amphibians protect hosts from this pathogen. This
project focuses on the anti-fungal mechanisms of Serratia marcescens, a species of
bacteria isolated from a Costa Rican frog that dramatically inhibited Bd in culture. Wildtype and recombinant S. marcescens was introduced to the microbiomes of a live
amphibian host, Acris blanchardi (Blanchard’s Cricket Frog) and then challenged with
Bd to examine the protective effects of this bacteria. The experiment includes
recombinant S. marcescens with the genetic pathway responsible for the production of
prodigiosin interrupted. This work observed significantly greater movement among frogs
treated with wild-type Sm when compared to the other bacteria treatments. There were
also significant differences in mean mass and snout-vent length (SVL) between the
washed and unwashed treatments. In particular, mean SVL was greater in washed frogs
compared to unwashed frogs of the wild-type Sm and no bacteria treatments. These
efforts will aid in the future conservation of amphibian species worldwide.

KEYWORDS: Batrachochytrium dendrobatidis, Chytridiomycosis, Serratia marcescens,
Genetic engineering
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CHAPTER ONE
Influences of Anti-Bd Bacteria on Amphibians

Introduction
Emerging infectious diseases are threatening populations of wildlife across the
globe and are of great focus in conservation efforts (Rachowicz et al., 2005). Any species
of plant or animal, including humans (Homo sapiens), can be affected by emerging
infectious diseases. Mycoplasmal conjunctivitis arose in house finches (Haemorhous
mexicanus) in the United States in the mid-1990s and Mycoplasma gallisepticum was
isolated from affected birds. This was the first time M. gallisepticum had been associated
with disease in wild birds (Williams et al., 2002). Caliciviruses causing rabbit
hemorrhagic disease were spread via globalization from rabbitries in China to Europe,
North Africa, Mexico, and eventually Australia and New Zealand. This marked the first
time the rabbit (Oryctolagus cuniculus) populations of Europe were exposed to this
particular virus and resulted in major population declines (Williams et al., 2002). The
Hendra and Menangle viruses were described and classified as paramyxoviruses after
emerging in in Australia in the mid-1990s. The Hendra virus expanded its host range
showing up in horses (Equus caballus) and humans. The Menangle virus first appeared in
piglets in Australia. Infection with the virus in pigs (Sus domesticus) led to smaller litters
and more stillbirths. The Menangle virus was also capable of infection in humans leading
to flu-like symptoms (Williams et al., 2002). Mycoplasmal conjunctivitis in house
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finches, hemorrhagic disease in European rabbit populations, and paramyxoviruses are all
examples of emerging infectious diseases and how they can affect many species.
There are more than 31,000 species classified as threatened with extinction
(International Union for Conservation of Nature [IUCN], 2020). This includes an
estimated 41% of all amphibian species (IUCN, 2020). This puts amphibians at greater
risk for extinction than birds (12%) or mammals (23%) (Stuart et al., 2004). There are
several hypotheses regarding global amphibian population declines including habitat loss,
land-use change, climate change, enigmatic decline, contaminants, and emerging
infectious diseases. There was major deforestation and drainage of wetlands in the 1800s
leading to rapid and large amphibian population declines in North America (Collins &
Storfer, 2003). Changes to amphibian habitat occur today, but are not the sole reason for
declines in recent decades. Global climate change, specifically, the average global rise in
temperature and drier than normal environment in rainforests has led to negative impacts
on the reproductive ability of amphibian species; therefore, creating population decline
(Beebee & Griffiths, 2005). One study provided evidence to support the thermal
mismatch hypothesis, which suggests amphibians from cooler climates are more
susceptible to death from Bd infection under warmer conditions than amphibians from
warm climates (Cohen et al., 2018). There are also many species of amphibians
experiencing seemingly inexplicable declines, known as “enigmatic decline” (Stuart et
al., 2004). Another likely contributor to population declines is the presence of
contaminants in amphibian habitat. It has been demonstrated that maternal transfer of
inorganic contaminants occurs among amphibians and negatively impacts the viability of
offspring (Hopkins et al., 2006). Another study found that the commonly used pesticide,
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Diuron was 100% lethal to bullfrog tadpoles (Lithobates catesbeianus) in concentrations
of 40 mg a.i./L or greater (Moreira et al., 2019). There is also evidence of a link between
neonicotinoid insecticide contaminants and immune suppression of animals leading to
greater infectious disease vulnerability (Mason et al., 2013). Immune suppression is one
way for emerging infectious diseases to occur. It allows for diseases to infect species that
otherwise would not be afflicted. The emerging infectious disease may then lead to
individual death and overall population decline.
There are many emerging infectious diseases contributing to amphibian declines
specifically. The first is ranavirus, which infects many amphibians leading to organ death
and hemorrhaging (Miller, Gray, & Storfer, 2011). Ranavirus has caused amphibian
population declines in North America and Europe (Cunningham et al., 1996; Green,
Converse & Schrader, 2002; Ariel et al., 2009). Chytridiomycosis is also of great concern
to amphibian populations on a global scale. Chytridiomycosis is a fungal infection
leading to death. Infection has been shown to be caused by two species of fungi,
Batrachochytrium salamandrivorans (hereafter Bsal) and Batrachochytrium
dendrobatidis (hereafter Bd). Bsal was identified as the cause of chytridiomycosis in fire
salamanders (Salamandra salamandra), which were experiencing major population
declines in the Netherlands (Martel et al., 2013). Salamanders exhibited symptoms of
anorexia, apathy, ataxia, and signs of skin lesions as a result of infection. The
salamanders ultimately died after seven days (Martel et al., 2013). The movement of Bsal
into Europe has caused rapid and seemingly unrecoverable amphibian declines and as
such represents a serious global threat to amphibians. Bsal has not yet established a
presence in North America, but the United States Geological Service (USGS) National
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Wildlife Health Center (NWHC) is working with the USGS Amphibian Research and
Monitoring Initiative (ARMI) to further test for the presence of Bsal in the United States
(United States Geological Service, 2016). Bd has a significant presence in North and
Central America (Longcore, Pessier & Nichols, 1999). Bd is causing chytridiomycosis
infection and significant amphibian population declines in over 200 species, threatening
biodiversity on a global scale (Harris et al., 2009a; Miaud et al., 2016). There are several
signs and symptoms indicative of Bd infection. First, mass can be measured and used as
an indicator of infection. Decreased mass over time has been shown in amphibians
infected with Bd (Harris et al., 2009b; Murone, DeMarchi & Venesky, 2016). Second,
snout-vent length (SVL) has exhibited a negative relationship with infection in
metamorphs (Kriger et al., 2006). Third, measures of lethargy, such as movement have
been used in the methods of previous studies examining infection with Bd of amphibians
(Voyles et al., 2007). Fast quantitative PCR is effective in diagnosing Bd infection by
testing for the presence or absence of Bd zoospores from swabs taken from amphibians
(Kerby et al., 2013).
There are a few host defenses against Bd that have been identified. Two key ones
are antimicrobial peptides secreted by the host and microbiome defense. Select species of
amphibians have immunity from Bd infection because they produce several skin peptides
with antimicrobial properties allowing them to fight the pathogen and avoid infection
(Woodhams et al., 2007a). The other mechanism of defense, the cutaneous microbiome
relies on the presence of anti-fungal bacteria residing within the amphibian microbiome.
Studies have shown that the presence of anti-fungal bacteria in the cutaneous microbiome
of amphibians improves Bd infection outcomes (Harris et al., 2009a; Harris et al., 2009b;
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Ibáñez et al., 2019). Emphasis on the amphibian microbiome is critical because
microbiomes are important in many cases of disease across species. For example, the
relative composition of human microbiomes significantly differs between healthy humans
and those suffering from various disease states, such as inflammatory bowel disease, type
2 diabetes, and necrotizing enterocolitis (Johnson & Versalovic, 2012). Bat microbiomes
have been shown to be influenced by many environmental factors and as such can serve
as an indicator of the host’s life history, physiology, and geography (Philips et al., 2012).
Another example is the rainbow trout (Oncorhynchus mykiss) microbiome. One study
found several bacterial species within the microbiome of the rainbow trout to inhibit
aquatic fungal pathogens (Lowrey et al., 2015). Bacterial species capable of inhibiting
fungal pathogens in amphibians have been isolated from amphibian microbiomes as well
(Harris et al., 2006; Madison et al., 2017). It is important to have identified these antifungal bacteria resident to amphibian microbiomes because the microbiome can also
influence the success of the animal’s reintroduction to the wild. It has been suggested that
non-resident bacteria introduced to microbiomes of animals do not persist in the animals’
native environment and thus, does not perform its intended function so the animal dies
after reintroduction (Redford et al., 2012). Both the previously mentioned examples of
the rainbow trout microbiome and amphibian microbiome studies utilized bacterial
species native to the hosts’ microbiomes in an effort to eliminate the risk accompanied by
non-resident bacteria (Lowrey et al., 2015; Harris et al., 2006; Madison et al., 2017). As
such, this study utilizes a strain of Serratia marcescens isolated from amphibian
populations in Costa Rica (Madison et al., 2017). One method for reducing the presence
of transient bacteria on captured amphibians is via rinsing or washing. It is thought the
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washing is simply effective for preventing the influence of environmental bacteria in
results (Lauer et al., 2008; Kueneman et al., 2014). However, it may also play a role in
increasing bacterial diversity of the microbiome (Madison et al., 2019). Thus, this study
also looks at other ways the washed treatment may have influenced the frogs.
The microbiome can be manipulated to provide an additional tool for defense
against Bd infection (Bletz et al., 2013). Bacteria that inhibits the growth of Bd must be
used in order to do this. Previous studies have identified many species of bacteria capable
of inhibiting Bd growth in vitro (Harris et al., 2006; Lauer et al., 2008; Madison et al.,
2017). This study examines the effects on amphibians of one of these bacterial species in
vivo. A couple of studies have shown inhibition of Bd in vivo, but did not investigate the
specific bacterial pathways responsible for this inhibition (Harris et al., 2009a; Harris et
al., 2009b).
Here, I used Serratia marcescens, the wild-type strain of which produces a known
anti-fungal agent, prodigiosin (Okamoto et al., 1998). I also used a genetically altered
strain of S. marcescens (pigM-Sm) that did not have the ability to produce prodigiosin to
determine whether or not prodigiosin was responsible for inhibiting Bd in vivo. I
hypothesized frogs treated with the wild-type S. marcescens and Bd would exhibit more
movement and maintain mass than those treated with the pigM-Sm and Bd.

Methods
I. Capture
Animals used in this experiment were wild caught Acris blanchardi. Metamorphs
were captured with nets or gloved hands in Nebraska along the Missouri River Valley.
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Metamorphs were used in this study based on natural availability. Collection of frogs was
permitted under a Nebraska Game and Parks Commission Scientific and Educational
Permit (#1006). After capture, each frog was put in an individual plastic bag placed in a
cooler for transportation to the University of South Dakota. At intake, the mass and
snout-vent length were measured of each frog. Mass and SVL were not significantly
different between frogs prior to experimentation. The frogs were also swabbed for the
presence of Bd as determined by qPCR. Half of the frogs were washed with 6 mL of
Nanopure water using a 1 mL pipette.

II. Housing
Experimentation with the frogs was in accordance with an approved University of
South Dakota IACUC protocol. All experimentation was done in a BSL-2 facility in the
animal care facility located at the University of South Dakota. Each frog was kept in an
individual plastic container, which had been sterilized prior to use via a four step process:
(1) plastic containers and lids were first submerged in a 10% bleach solution for one
minute; (2) rinsed with tap water; (3) wiped down with a 70% solution of ethanol; and (4)
lastly, rinsed with Nanopure water. Every container held a bed of Coco Husk (Exo Terra,
Rolf C. Hagen Corp., Mansfield, MA, USA), which was sterilized via autoclave (15 m,
121˚ C). The environment was kept at 20.5˚-21˚C and light/dark cycles set to represent
the natural conditions of 42.5˚ N.
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III. Treatments
Individual frogs were kept under 12 treatment conditions representing a 2x2x3
factorial design (table 1): live Bd or no-Bd; washed or unwashed; and no S. marcescens
(hereafter Sm), wild-type Sm, or pigM-Sm.

Table 1. The number of frogs kept under each treatment condition.
Treatments

No Sm

ΔpigM-Sm

Wild-type Sm

Unwashed (no Bd)

9

7

9

Washed (no Bd)

9

7

8

Unwashed + Bd

9

7

10

Washed + Bd

8

8

8

The wild-type Sm strain used was previously isolated and characterized by our laboratory
from the microbiome of a Costa Rican frog (Madison et al., 2017). The pigM-Sm was
developed in our laboratory by disrupting the prodigiosin producing gene (pigM) with the
insertion of a kanamycin resistance cassette (Madison et al., 2017). Frogs were given 48
hours to acclimate before introduction of the treatments. Each treatment held at least 7
frogs. First, individuals were randomly selected to receive treatment of the control broth
only (LB-Miller), wild-type Sm (~35 x 106 cells/mL), or pigM-Sm (~12 x 106 cells/mL).
This was done by placing each frog in a 50.0 mL tube containing 10.0 mL of its
respective treatment for 30 minutes. Following this treatment, individuals were held for
three days before the introduction of Bd to allow for the establishment of Sm to the
microbiome. The frogs were then placed in treatment tubes containing either the control,
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tryptone-gelatin-hydrolysate-lactose (TGhL) broth only, or Bd and TGhL (~1.125 x 108
zoospores/mL) broth for 30 minutes. Again, each frog was placed in a 50.0 mL tube with
10 mL of treatment. The washed treatment was applied at the time of intake prior to the
48 hour acclimation period.

IV. Monitoring
Each frog was sprayed three times with autoclaved spring water daily. Following
the spray, the frog was observed for 20 seconds to record movement. Movement qualified
as a change in position of the entire body of the frog. Frogs were fed with two crickets
three times a week. For the duration of the experiment, all frogs were measured weekly
for mass and SVL. They were also swabbed twice each week: (1) to determine presence
of Bd and (2) for sequencing of the microbiome. Sterile rayon swabs were used to
complete swab samples with three strokes ventral and three strokes dorsal on each frog
(Becker et al., 2014). The swabs were then frozen at -20C to preserve them for later
analysis via qPCR. Frogs alive at the end of the experiment were euthanized via a topical
application of Benzocaine (Orajel, Church and Dwight Canada Corp., Mississauga,
Ontario, Canada). Frogs that died prior to the end of the experiment were massed and
stored in a freezer at -20C.
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V. qPCR
qPCR was done in accordance with a previously developed protocol to determine
presence or absence of Bd prior to experimental introduction and to confirm infection
post-introduction (Kerby et al., 2013). The total reaction volume was 10 L with 3 L of
template DNA, 900 nmol of forward primer, 900 nmol of reverse primer, and 250 nmol
minor groove binder (MGB) probe, and 2X Taqman Fast Universal Master Mix (Applied
Biosystems, Foster City, CA, USA). On each plate, there was a control of Nuclease-Free
water (Thermo Fisher Scientific, Waltham, MA, USA) and a series of standards with
concentrations ranging from 0.06-60 zoospore equivalents to create a standard curve to
compare samples against. Plates were run on a Quant Studio 4 qPCR machine at an
activation stage of 95 C for 20 s, followed with 50 cycles of 95 C for 3 s and 60 C for
30 s (Kerby et al., 2013).

VI. Analysis
Statistical analyses were completed in RStudio version 1.1.383 (RStudio, Inc.,
Boston, MA, USA). Analysis of variance tests were performed to identify potential
effects of the Bd, bacteria, and washed/unwashed treatments on the response variables of
movement, mass, and SVL of the frogs. Movement data was summed over the first eight
days of the experiment. Mean mass, change in mass, and mean SVL data was calculated
using the values through the fourth week of the study. These time frames were selected
due to greater instances of frog mortality beyond these periods. The treatments were
specifically compared against the sum of movement, mean and change in mass, and mean
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SVL data. Post hoc Tukey pairwise tests were then completed on any significant
findings.

Results
I. Movement
There was a significant difference in the number of instances of movement
between bacteria treatments (F2,90=4.361, p=0.016). There was greater movement in frogs
of the wild-type Sm treatment (mean=5.44, SD=1.73) compared to the other two
treatments (-pigM Sm mean=4.34, SD=1.64; no Sm mean=4.42, SD=1.72) (figure 1).
No difference was found in movement among the Bd treatments (F1,90=0.004, p=0.96) or
the interaction of Bd and bacteria (F2,90=2.363, p=0.10).

Mean Instances of Movement

7
6
5
4
3
2
1
0
Wild -typ e Sm

No Sm

∆pigM-Sm

Figure 1. Mean number of times movement occurred over the sum of eight days between
bacteria treatments with standard error. Frogs treated with wild-type Sm moved
significantly more than frogs of the other bacteria treatments.
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II. Mass
Washing produced a difference in mean mass (F1,84=8.71, p=0.004). Washed
frogs (mean=0.36 g, SD=0.11) had greater mean mass than frogs of the unwashed
treatment (mean=0.29 g, SD=0.12) (figure 2). There were no relationships between mean
mass and Bd (F1,84=0.136, p=0.71), bacteria treatments (bacteria F2,84=1.472, p=0.24), or
their combinations (Bd:bacteria F2,84=0.451, p=0.64; Bd:washed/unwashed F1,84=0.139,
p=0.71; Bacteria:washed/unwashed F2,84=2.786, p=0.07; and
Bd:bacteria:washed/unwashed F2,84=2.494, p=0.09).

0.4
0.35

Mean Mass (g)

0.3
0.25
0.2
0.15
0.1
0.05
0
Wa shed

Unwashed

Figure 2. Mean mass over the first four weeks between frogs of the washed and
unwashed treatments with standard error. Washed frogs had significantly greater mass
than the unwashed frogs.

There was a small, yet significant decrease in mass for frogs (p<0.05) within all
treatment groups from days 1 to 35, except for the no-Sm + Bd, unwashed treatment.
Differences in mass between treatments on the same days were not significant (p>0.05).
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No significant relationships were found when comparing all treatments against
change in mass (Bd F1,89=1.631, p=0.21; bacteria F2,89=1.883, p=0.16; Bd:bacteria
F2,89=0.272, p=0.76; washed/unwashed F1,91=1.510, p=0.22; and Bd:washed/unwashed
F1,91=0.102, p=0.75).

III. Snout-Vent Length
SVL was significantly influenced by washing (F1,84=7.442 and p=0.008). Washed
frogs (mean=1.61 cm, SD=0.19) had greater mean SVLs than unwashed frogs
(mean=1.51 cm, SD=0.19) (figure 3).

1.7

Mean SVL (cm)

1.65
1.6
1.55
1.5
1.45
1.4
Wa shed

Unwashed

Figure 3. Mean SVL of washed and unwashed frogs with standard error. Washed frogs
had a significantly greater SVL compared to the unwashed frogs.
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Another significant difference existed in the mean SVLs between washed and
unwashed frogs of the no Sm and wild-type Sm treatments (F2,84=5.420, p=0.006).
Washed frogs under the wild-type Sm and no Sm treatments had greater mean SVLs
(wild-type Sm, mean=1.68 cm, SD=0.14; no Sm, mean=1.62 cm, SD=0.17) than their
unwashed counterparts (wild-type Sm, mean=1.52 cm, SD=0.20; no Sm, mean=1.41 cm,
SD=0.18) (figure 4). No such relationship was observed among the washed and
unwashed frogs of the pigM-Sm treatment. All other treatments and their respective
relationships with mean SVL were insignificant (Bd F1,84=0.003, p=0.96; bacteria
F2,84=1.746, p=0.18; Bd:bacteria F2,84=0.034, p=0.97; Bd:washed/unwashed F1,84=0.357,
p=0.55; and Bd:bacteria:washed/unwashed F2,84=1.707, p=0.19).

Figure 4. Interaction plot of the bacteria and washed/unwashed treatments for mean SVL.
Washed frogs of the wild-type Sm and no bacteria treatments have significantly greater
SVLs than the unwashed frogs of the same bacteria treatments. This difference was not
observed between washed and unwashed frogs of the -pigM Sm treatment.
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Discussion
This is the first time recombinant Sm with an interrupted prodigiosin anti-fungal
pathway has been used in an in vivo amphibian system. Previous studies have shown
improvements in disease outcome with the introduction of anti-fungal bacteria species to
the cutaneous microbiome of amphibians (Harris et al., 2009a; Harris et al., 2009b). We
hypothesized the frogs treated with pigM-Sm and Bd would produce less movement and
experience more mass loss than the frogs treated with wild-type Sm and Bd. However, the
most interesting difference found in this experiment is that average mass was greater in
unwashed versus washed treatments. Washed frogs also had a higher average SVL than
the unwashed frogs. This is of particular interest because in previous studies washing has
served as an appropriate method for removing transient bacteria and debris from
amphibians to prevent their influence on results, while having thought it affected other
variables very little to not at all (Lauer et al., 2008; Kueneman et al., 2014; Walker et al.,
2015). The reason for this relationship between washing and greater mass and SVL is
unclear. Previous research suggests that washing does remove transient bacteria to ensure
microbiome analysis is of primarily amphibian-associated bacteria (Culp, Falkinham, &
Belden, 2007; Lauer et al., 2007). It is unknown whether washing may remove inhibitory
factors to growth such as potentially harmful bacteria or environmental contaminants. It
is also possible that washing removes some cutaneous Bd zoospores if they existed on the
frog prior to experimentation. This discrepancy ultimately calls for further research on
the use of washing as a method in amphibian research due to its unintended influences on
other variables.
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Another interesting relationship found was that between the interaction of the
bacteria treatments with washed/unwashed treatments and the mean SVL variable. The
washed frogs treated with wild-type Sm and no bacteria had much greater SVLs than their
unwashed counterparts, but no significant difference was found between the washed and
unwashed frogs of the pigM-Sm treatment. This may further indicate the importance of
the influence of washing even under the other treatments of this experiment. It is not clear
why these differences exist. It may be that wild-type Sm was better able to establish a
population within the microbiome after the wash. This establishment may have then led
to an enhanced symbiotic relationship with the frog leading to the maintenance or gain of
SVL over time. However, the observation that washed frogs with no introduced bacteria
also experienced this difference in SVL does not support that wild-type Sm would have
such an effect. Another possibility is that the introduction of pigM-Sm within the
microbiome had a unique influence within the microbiome and in its relationship with the
frog host. Establishment of pigM-Sm may not require the removal of transient bacteria
or the removal of transient bacteria does not provide an advantage for pigM-Sm to
establish a population within the cutaneous microbiome. The introduction of pigM-Sm
appears to nullify the effects of the washed/unwashed treatment observed under the other
bacteria treatments. Further research is required to determine why.
Mass as a measure can be used for indicating effects of Bd infection or lack
thereof (Harris et al., 2009b). This experiment measured SVL to investigate any potential
relationships with disease outcomes post-infection of Bd. Third, movement was measured
in this experiment because decreased movement is indicative of infection (Carver, Bell,
& Waldman, 2010). Frogs treated with wild-type Sm moved more than frogs under the
16

pigM-Sm treatment. This result supports our hypothesis. It is most likely the wild-type
Sm established a population within the cutaneous microbiomes of the frogs and
developed a strong symbiotic relationship. This establishment would allow for the antifungal capabilities of the bacteria to take effect in the presence of Bd. This was
anticipated since the wild-type strain retained its prodigiosin pathway. Frogs exposed to
the pigM-Sm instead of the wild-type Sm exhibited less movement. This was also
anticipated because the lack of prodigiosin production in the recombinant strain reduced
its anti-fungal capabilities likely leading to greater Bd infection in those frogs.
Identifying the role of the aforementioned significant relationships between treatments
and measures in disease outcomes brings opportunities for further investigation into new
prevention and treatment possibilities of chytridiomycosis, the disease caused by Bd.
Examining Bd in Blanchard’s cricket frogs is important because they are declining across
parts of their range and this could partially be due to Bd. Many species of amphibians are
experiencing decline at least partially due to Bd infection, so this research is also
important in helping combat global amphibian declines. To have the widest reach, it is
also important to identify several effective bacteria species for this potential microbiome
engineering treatment. Using bacteria native to the microbiome of the respective animal
has also shown to be important in success of reintroduction to the wild, so identifying
several anti-fungal bacteria is critical to developing this as a successful treatment of
infection (Redford et al., 2012). Other studies used different species of bacteria shown to
be effective in vivo against Bd, such as Pseudomonas reactans and Janthinobacterium
lividium (Harris et al., 2009a; Harris et al., 2009b). This experiment examined the
potential of Sm to be another one of these effective bacteria species. This also has
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implications in disease outcomes of other wildlife, such as bat populations affected by
white-nose syndrome, which is caused by a pathogenic fungus, Pseudogymnoascus
destructans (Hoyt et al., 2015). In addition, bacterial microbiomes are known to defend
plants from pathogens (Berendsen, Pieterse, & Bakker, 2012). As such, microbiomes of
other animals and plants could be engineered to assist in defense against pathogens. It has
even been suggested that microbiome engineering of this manner could be used to treat
diseases in humans (Schwabe & Jobin 2013). Further research is required to determine
the viability of microbiome engineering as a treatment of infection in wild animals. There
are many obstacles to overcome, such as survival of animals with engineered
microbiomes post-reintroduction. Investigation of unintended consequences, such as
those seen with washing in this study, is required before this treatment can be widely
used.
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CHAPTER TWO
Influences of Anti-Bd Bacteria on Amphibian Microbiomes

Introduction
Microbiomes have shown great importance in the health of their hosts, yet many
details of microbiome-host interaction remain unknown (Miles, Jonathan, & Handelsman,
2015; Cho & Blaser, 2012). The introduction of new bacteria to the microbiome has
shown to influence host health when facing infection (Harris et al., 2009a). Although this
interaction between bacteria and host health has been well studied, the changes in
microbiome diversity due to a new bacteria species have not. Another concept that has
yet to be studied in depth is the genetic recombination of bacteria species for the
enhancement of a desired function (e.g., ability to fight fungal infection) of the
microbiome. The methods for genetic engineering of this kind has been examined in bees
(Apis mellifera) and mice (Mus musculus) (Leonard et al., 2018; Mimee et al., 2015).
However, the use of these tools has an unknown influence on the diversity of the
microbiome when introduced as treatment for host disease. This is an important area of
study to make the introduction of recombinant bacteria to the microbiome a viable
treatment option for host disease.
A major host disease of interest is chytridiomycosis, which is an infection of
amphibians caused by the fungus, Batrachochytrium dendrobatidis (Bd) (Longcore,
Pessier, and Nichols, 1999). Bd is causing serious amphibian population declines on a
global scale (Vredenberg et al., 2010). Despite global declines, there are some amphibian
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species that exhibit immunity to Bd infection (Whitfield et al., 2017). This immunity is
likely due to some combination of unique major histocompatibility complexes (MHC) of
the adaptive immune response, secretion of anti-microbial peptides, and resident bacteria
of the cutaneous microbiome (Fu and Waldman, 2017; Bataille et al., 2015; Woodhams et
al., 2007a; Woodhams et al., 2007b; Rebollar et al., 2016). The cutaneous microbiome
holds the most potential for exploration and manipulation in efforts to combat Bd
infection because of its proximity to the site of infection. Research thus far has led to the
introduction of known anti-fungal bacteria native to the amphibian host microbiome
(Lauer et al., 2008; Harris et al., 2006; Redford et al., 2012; Harris et al., 2009a; Harris et
al., 2009b).
There are several known anti-Bd bacteria species (Woodhams et al., 2015).
Serratia species are of particular interest in this study because of their antifungal
properties. These include the production of chitinases and glucanases, the type-VI
secretion system, and production of prodigiosin (Monreal & Reese, 1969; Trunk et al.,
2018; Okamoto et al., 1998). Serratia is also of interest because it is commonly found in
the microbiomes of Anura and Caudata (Woodhams et al., 2018). In this study, we
focused on the prodigiosin pathway by introducing either a recombinant strain of Serratia
marcescens with the pathway disabled (pigM-Sm) or a wild-type strain of Sm. We
hypothesized that introduction of wild-type Sm versus pigM-Sm would lead to
significant differences in microbiome community structure relative to each strain and
Blanchard’s Cricket Frog (Acris blanchardi) response when challenged with Bd. We also
hypothesized that these differences would be influenced by time, particularly the effects
of time on microbiome diversity between treatments.
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Methods
The same experimental subjects were used as in the previous chapter. Capture,
housing, and treatments are summarized below, but see Chapter 1 for complete details.

I. Capture and Housing
Metamorph A. blanchardi were caught with gloved hands in Nebraska along the
Missouri River Valley as described in Chapter 1. All frogs were housed in sterilized
individual plastic containers under regulated conditions and temperatures per housing
methods detailed in Chapter 1.

II. Growth Assays
Growth assays were completed to develop growth curves for each of the
following strains of bacteria: wild-type Sm and pigM-Sm. In addition, there were two
broth only (LB-Miller) controls, one for each strain. Growth was carried out at 21C.
Concentration measurements of the bacteria growth for both strains were done every 24
hours with a spectrophotometer (OD=600). Samples were normalized for cell
concentration as to have the same baseline.
Challenge assays were carried out using methods per Bell et al. (2013) to examine
the effects of each strain of Sm on Bd growth. Varying concentrations of Sm supernatant
(from centrifuged culture, 0.22 m filter-sterilized) were placed in 96 well plates.
Starting growth values for beginning Bd concentration were normalized for all wells. Bd
only dilution cultures were also created and examined to control for potential influence of
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nutrient limitations. Growth of the challenge assays and Bd only dilution cultures was
done at 21C for 8 days.

III. Treatments
Individual frogs were kept under the 12 treatment conditions representing and
2x2x3 factorial design described in detail previously (Table 1, Chapter 1): live Bd (JEL
423), no-Bd; washed, unwashed; and no Sm, wild-type Sm, pigM-Sm. All treatments had
at least seven frogs up to ten. Treatment introduction and washing were completed as
described in Chapter 1.

IV. DNA Extraction and Purification
Proteinase K digestion of all swab samples was done overnight at 56C. DNA
extraction was completed using the Qiagen (Hilden, Germany) DNeasy Blood and Tissue
kit according to manufacturer’s directions. Extracted DNA was then cleaned and
concentrated using the ZR-9 Genomic DNA Clean and Concetrator-5 kit (Zymo
Research, Irvine, CA, USA).

V. qPCR
qPCR was done in accordance with a previously developed protocol to determine
presence or absence of Bd and are detailed in Chapter 1 (Kerby et al., 2013). Samples
were compared against controls lacking DNA and a standard curve of the Bd ribosomal
internal transcribed spacer (ITS) gene. A sample was considered positive when two or
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more of the three replicates indicated amplification and mean detection was at least 0.1
zoospore (9.8 copies) per previous research (Blooi et al., 2013).

VI. Library Preparation and Next-Generation Sequencing
All library preparation and sequencing was completed in WestCore at Black Hills
State University (Spearfish, SD, USA) as is offered in Madison, Ouellette, Schmidt &
Kerby (2019).

VII. Sequence Data and Statistical Analysis
Processing and analysis of raw sequencing data was done using Mothur v.1.39.5
(Schloss et al., 2009). The MiSeq standard operating procedure was followed starting
with generating contigs from paired-end reads, clean-up steps (including screening,
filtering and chimaera removal using UCHIME), alignment to the Silva database [1.32],
and generation of operational taxonomic units (OTUs) for statistical analysis (Kozich et
al., 2013; corresponding webpage accessed 29 January 2018) according to Madison,
Ouellette, Schmidt & Kerby (2019).
All statistical analyses were performed in R v.3.4.3. Linear models and repeated
measures ANOVA were used in analysis of the in vitro experiments and measurements.
Multiple treatment comparisons were made using estimated marginal means (EMMs) and
Tukey’s pairwise tests. This was done with the emmeans package (Madison et al., 2019)
Linear mixed-effects models were used to analyze the in vivo experimental
results. Package lme4 was used to create the models of the relationship between the
response variable and predictor variables: treatment, day, and individual (Madison et al.,
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2019). A day-treatment interaction term was entered as a fixed effect. Individual frogs
were included in the model as a random effect. The response variable used between
models was of either inverse Simpson diversity, mass (g), Bd presence/absence or
Serratia abundance. Visual inspection of residual plots in all models did not reveal any
obvious deviations from normality or homoscedasticity. Model selection was carried out
by likelihood ratio tests of the full model with the day-treatment interaction effect in
question. Further post hoc testing with EMMs comparisons and Tukey’s pairwise tests
between treatments and between days was completed using the emmeans package
(Madison et al., 2019).
All scripts and models used for the analysis of results presented in this paper have
been deposited in GitHub (https://github.com/kvasir7/Acris_microbiome) and are
publicly accessible. All 16S rRNA gene sequences have been deposited in the NCBI
Sequence Read Archive (BioProject: PRJNA435631).

Results
As is presented in Madison, Ouellette, Schmidt & Kerby (2019), Bd growth was
significantly reduced in the presence of wild-type Sm in vitro compared to the pigM-Sm
(p=0.014) and the Bd only control (p<0.0001). In vivo, the interaction between treatment
and time significantly predicted frog mass, bacterial community inverse Simpson
diversity, Bd presence/absence, and Sm abundances (p<0.05). The presence of zoospores
was not significantly different between treatment groups at the same points in time
(p<0.05). Bd was detected before the experimental introduction of Bd. This indicates
some Bd prevalence in the environment where frogs were captured. Despite this finding,
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Bd infection still qualitatively increased one week after exposure to Bd; this included
individuals that were negative for Bd. Bd was absent from all remaining live frogs three
weeks after initial experimental exposure.

I. Inverse Simpson Diversity
As is shown in Madison, Ouellette, Schmidt & Kerby (2019) there was a
significant increase in diversity of the microbiome between day 1 and 29 in both washed
and unwashed pigM-Sm treatments (p=0.033 and p<0.0001, respectively) and in the
washed control treatment (p=0.001). No significant change in inverse Simpson diversity
was seen in the unwashed control or wild-type Sm treatments. It is also important to note
that Serratia became a chief component (greater than 10.0% for at least one time point)
of the microbiome after introduction of either strain (figure 5).

Figure 5. Bar graphs showing relative abundance (%) of bacterial genera comprising
greater than 10% of the microbiome at a minimum of one time point.
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II. Survival
Survival curve analysis from Madison, Ouellette, Schmidt & Kerby (2019)
revealed a significant difference between bacteria treatments in the unwashed + Bd group
(figure 6, p(global)<0.001, d.f.=2). In the unwashed + Bd group, the pigM-Sm treatment
showed a significantly decreased likelihood of survival compared to the wild-type Sm
treatment (p=0.00026, d.f.=1). Significant differences were not observed in comparing
the other bacteria treatments, wild-type Sm and no Sm, in the unwashed + Bd group
(p>0.05, d.f.=1). There were also no significant differences in survival observed between
bacteria treatments in the washed + Bd group or in either of the no-Bd groups. A
significantly higher survival rate was observed in the unwashed + Bd + no-Sm treatment
when compared with the washed + Bd + no-Sm treatment (p=0.0071, d.f.=1).

Figure 6. Survival plots with panels faceted by treatment conditions washed/unwashed
and Bd/no-Bd. Curves in each sub-plot are color-coded by bacterial treatment: mutant
(pigM) Sm, wild-type Sm or no-Sm (given in figure legend). There is a significant
difference between the curves of the Bd-unwashed sub-plot (p<0.001).
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Discussion
Using genetically engineered bacteria for fighting infection has yet to be
thoroughly researched enough to allow for implementation. This experiment showed that
inoculation of A. blanchardi with wild-type Sm or pigM-Sm alters the microbiome
diversity and survival of the host when challenged with Bd. The recombinant Sm was
associated with greater microbiome diversity, but lower probability of host survival. This
means the specific functions of a particular species of bacteria can have major effects on
microbiome diversity, but not necessarily to the survival benefit of the host.
The low levels of Bd detected prior to experimental introduction of Bd JEL 423 is
consistent with previous and current reports on Bd presence in the Midwestern United
States (Steiner & Lehtinen, 2008). This was useful for this study as it was our goal to
examine potential microbial therapies on amphibian populations that are not naïve to Bd,
but potentially vulnerable to more virulent strains. The Bd strain JEL 423 used in this
experiment is known for its high virulence (Hambalek, 2016); however, the individual
frogs used in this experiment were only partially susceptible. It is possible environmental
Bd exposure prior to capture or factors due to captivity influenced their susceptibility, but
it remains poorly understood. It is also important to note the lack of Bd three weeks postexposure. This is probably due to the death of infected frogs or the clearing of Bd by live
frogs. It is possible that mortality among captured frogs could have been due to factors
outside of Bd infection, such as pre-capture environmental factors or developmental
stage. However, Bd was still a clear factor among treatment conditions for either having
caused or was a significant factor in the observed differences in mortality between
bacterial treatments.

27

Another interesting result was that bacterial community diversity of the host
microbiome significantly increased over time in the pigM-Sm and washed control
treatment groups. The increase in diversity with pigM-Sm may be due to the lack of the
prodigiosin, since prodigiosin represents an inhibitory factor to bacterial growth. For
instance, wild-type Sm with an intact prodigiosin pathway uses it to kill other bacteria
species; therefore, reducing diversity. The increase of diversity in the washed control
treatment may indicate that washing promotes microbiome diversity. The reasons for this
are poorly understood but could be due to recolonization from the gut microbiome of the
frog. This could occur since the gut microbiome is more stable in captivity than the
cutaneous microbiome (Becker et al., 2014). Instead, washing may be responsible for
removing a less adherent and dominant bacteria species from the microbiome allowing
other bacteria to take its place. The removal of one species leaves a niche open for others.
The availability of niches like this is important in the application of probiotics and
therefore, may be important here as well (Zmora et al., 2018). Increased diversity of the
microbiome does not necessarily mean increased odds of host survival when facing
infection, however. Although pigM-Sm inoculation was associated with increased
diversity of the microbiome, it was also associated with decreased probability of survival
when challenged with Bd compared to wild-type Sm. In addition to loss of anti-bacterial
ability, the loss of prodigiosin in pigM-Sm may also decrease survival in hosts, since
prodigiosin is a known anti-Bd factor.
This study provides important information in showing the potential of genetic
engineering and introduction of bacteria to host microbiomes for the treatment of disease.
However, doing this in a predictive way is an important goal for implementation in wild
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or laboratory settings. Another important feature to develop is the ability to up- and
down-regulate protein or metabolite production of introduced bacteria. This would serve
as an important safety feature to manage unintended effects on the host and the
ecosystem (Smith, Van Elsas, & Van Veen, 1992). This methodology for the treatment of
emerging infectious disease presents many challenges, yet has the potential to
dramatically change treatment since there are few options. The results presented in this
study, therefore, provide important insight into the use of genetically modified bacteria
species in the management of host disease.
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